Product image of Ondansetron B. Braun (Ondansetron) supplied by GNH India

Ondansetron B. Braun

Active Ingredient:
Ondansetron
Origin:
EU

Ondansetron B. Braun (Ondansetron)

Ondansetron, the active ingredient in Ondansetron B. Braun, is a 5‑HT3 receptor antagonist presented as an intravenous solution for intravenous use. It is employed to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, and postoperative conditions in adult patients.

GNH India supplies Ondansetron B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide, with distribution aligned to EU market standards. The company ensures quality and regulatory compliance throughout the supply chain through rigorous testing and documentation.

Manufacturer / TM Owner

B.Braun Melsungen Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ondansetron acts on the serotonergic pathway to control emesis in several clinical settings.
  • Chemotherapy-induced nausea and vomiting: reduces incidence and severity of acute and delayed episodes.
  • Radiotherapy-induced nausea and vomiting: prevents onset of nausea during and after treatment.
  • Postoperative nausea and vomiting: minimizes postoperative symptoms and improves patient comfort.

How It Works

  • Ondansetron selectively antagonizes serotonin (5‑HT3) receptors located in the chemoreceptor trigger zone of the brain and on vagal afferents in the gastrointestinal tract. By blocking these receptors, it inhibits the transmission of emetic signals, thereby reducing the sensation of nausea and the act of vomiting.

Side Effects

Common Side Effects

  • Headache: mild to moderate intensity.
  • Constipation: occasional bowel movement difficulty.
  • Dizziness: transient sensation of lightheadedness.
  • Fatigue: general feeling of tiredness.
  • Diarrhea: loose stools in some patients.
  • Injection site reactions: redness or discomfort at the IV site.

Serious or Rare Side Effects

  • QT interval prolongation: may lead to cardiac arrhythmias.
  • Severe allergic reactions: anaphylaxis or angioedema.
  • Serotonin syndrome: risk when combined with other serotonergic agents.
  • Hypotension: sudden drop in blood pressure.
  • Cardiac arrhythmia: irregular heart rhythm.
  • Hepatic dysfunction: abnormal liver enzyme elevations.

Precautions & Warnings

  • Precautions should be observed when using Ondansetron B. Braun.
  • Renal impairment: adjust dose or monitor closely in patients with reduced kidney function.
  • Hepatic impairment: consider dose modification for patients with liver disease.
  • Electrolyte disturbances: correct potassium or magnesium abnormalities before administration.
  • Concomitant QT‑prolonging drugs: use with caution to avoid additive cardiac effects.
  • Pregnancy: risk unknown; prescribe only if benefits outweigh potential risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Ondansetron may interact with several medications.

Major Interactions (Avoid)

  • Other QT‑prolonging agents: increase risk of arrhythmia.
  • Apomorphine: may cause severe hypotension.
  • Serotonergic drugs (e.g., SSRIs, MAO inhibitors): risk of serotonin syndrome.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole): may increase ondansetron levels.
  • CYP3A4 inducers (e.g., rifampin): may reduce ondansetron efficacy.
  • Aminoglycoside antibiotics: may enhance QT prolongation risk.

Frequently Asked Questions

Ondansetron B. Braun is used to prevent and treat nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery in adult patients. It is administered intravenously under medical supervision to control emetic symptoms in these clinical settings.

Ondansetron works by selectively blocking serotonin 5‑HT3 receptors in the chemoreceptor trigger zone of the brain and in the gastrointestinal tract. This inhibition prevents the transmission of nausea and vomiting signals, providing effective antiemetic control.

The dose of Ondansetron B. Braun is determined by the prescribing clinician based on the specific indication, patient characteristics, and treatment protocol. It is administered intravenously and the exact regimen should be individualized by a qualified healthcare professional.

Safety data for Ondansetron during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the fetus or infant, and treatment decisions should be made under the guidance of a qualified healthcare provider.

To order Ondansetron B. Braun, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed), and import documentation.

Compared with dopamine antagonists, Ondansetron offers a more targeted mechanism by blocking 5‑HT3 receptors, resulting in fewer extrapyramidal side effects. It is effective for both acute and delayed phases of chemotherapy‑induced nausea, making it a preferred option in many oncology protocols.

Ondansetron B. Braun should be stored at 2‑8 °C. Keep the product refrigerated, protect it from light, and avoid freezing or shaking the vial to maintain its stability and efficacy.

Ondansetron B. Braun is administered intravenously. The solution is typically diluted in a compatible IV fluid and infused over a few minutes under clinical supervision, following the dosing instructions provided by the prescribing clinician.

Serious risks include QT interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, and serotonin syndrome when combined with other serotonergic agents. Patients should be monitored for these events, especially if they have underlying cardiac conditions or are on interacting medications.

Ondansetron B. Braun should be avoided in patients with known hypersensitivity to ondansetron or other 5‑HT3 antagonists, those with congenital long QT syndrome, and individuals taking contraindicated medications that may cause dangerous cardiac effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT